Grape seed proanthocyanidins induce apoptosis through p53, Bax, and caspase 3 pathways.
Grape seed proanthocyanidins (GSP) have been shown to inhibit skin chemical carcinogenesis and photocarcinogenesis in mice. The mechanisms responsible for the anticarcinogenic effects of GSP are not clearly understood. Here, we report that treatment of JB6 C141 cells (a well-developed cell culture model for studying tumor promotion in keratinocytes) and p53+/+ fibroblasts with GSP resulted in a dose-dependent induction of apoptosis. GSP-induced (20-80 g/ml) apoptosis was observed by using immunofluorescence (27-90% apoptosis) and flow cytometry (18-87% apoptosis). The induction of apoptosis by GSP was p53-dependent because it occurred mainly in cells expressing wild-type p53 (p53+/+; 15-80%) to a much greater extent than in p53-deficient cells (p53-/-; 6-20%). GSP-induced apoptosis in JB6 C141 cells was associated with increased expression of the tumor-suppressor protein, p53, and its phosphorylation at Ser15. The antiapoptotic proteins, Bcl-2 and Bcl-xl, were downregulated by GSP, whereas the expression of the pro-apoptotic protein, Bax, and the levels of cytochrome c release, Apaf-1, caspase-9, and cleaved caspase 3 (p19 and p17) were markedly increased in JB6 C141 cells. The downregulation of Bcl-2 and upregulation of Bax were also observed in wild-type p53 (p53+/+) fibroblasts but was not observed in their p53-deficient counterparts. These data clearly demonstrate that GSP-induced apoptosis is p53-dependent and mediated through the Bcl-2, Bax, and caspase 3 pathways.
Roy
Anshu M
AM
Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Baliga
Manjeshwar S
MS
Elmets
Craig A
CA
Katiyar
Santosh K
SK
D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D053477:Apoptotic Protease-Activating Factor 1; D053148:Caspase 3; D020169:Caspases / Q000378:metabolism*; D002478:Cells, Cultured; D045304:Cytochromes c / Q000378:metabolism; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D044945:Proanthocyanidins / Q000494:pharmacology*; D011506:Proteins / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism*; D012639:Seeds / Q000737:chemistry; D015398:Signal Transduction; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*; D027843:Vitis / Q000737:chemistry*; D051028:bcl-2-Associated X Protein; D051020:bcl-X Protein
C506593:Apaf1 protein, mouse; D053477:Apoptotic Protease-Activating Factor 1; C494827:Bax protein, mouse; C494812:Bcl2l1 protein, mouse; D044945:Proanthocyanidins; D011506:Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D016159:Tumor Suppressor Protein p53; D051028:bcl-2-Associated X Protein; D051020:bcl-X Protein; D045304:Cytochromes c; C505409:Casp3 protein, mouse; D053148:Caspase 3; D020169:Caspases
Cancer Res. 2003 Aug 1;63(15):4396-401
12907610
Genes Dev. 2001 Nov 15;15(22):2922-33
11711427
Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11
1933891
EMBO J. 1997 Mar 17;16(6):1391-400
9135154
Nature. 1979 Oct 18;281(5732):589-91
492322
Cell. 1997 Oct 31;91(3):325-34
9363941
Cell. 2004 Jan 23;116(2):235-46
14744434
Carcinogenesis. 2003 Aug;24(8):1379-88
12807737
Biochem Pharmacol. 2003 Oct 15;66(8):1547-54
14555233
Nature. 1992 Mar 19;356(6366):215-21
1552940
Curr Opin Cell Biol. 2001 Jun;13(3):332-7
11343904
Carcinogenesis. 1999 Feb;20(2):237-42
10069459
Science. 1997 Feb 21;275(5303):1132-6
9027315
EMBO J. 1999 Dec 15;18(24):7002-10
10601022
Cell. 1996 Jul 12;86(1):147-57
8689682
Nucleic Acids Res. 1994 Sep;22(17):3551-5
7937055
Mol Cell Biochem. 1999 Jun;196(1-2):99-108
10448908
Curr Pharm Biotechnol. 2001 Jun;2(2):187-200
11480422
Free Radic Res. 2001 Aug;35(2):181-94
11697199
EMBO J. 1998 Aug 17;17(16):4657-67
9707425
Biochem Pharmacol. 1990 Nov 15;40(10):2353-62
2244936
Cell. 1994 Aug 26;78(4):539-42
8069905
Trends Pharmacol Sci. 1992 Jun;13(6):245-51
1631963
Cell. 1994 Aug 26;78(4):703-11
8069917
Toxicol Appl Pharmacol. 2001 Oct 15;176(2):110-7
11601887
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
6606682
Nature. 1997 Feb 13;385(6617):637-40
9024662
J Med Food. 2003 Winter;6(4):291-9
14977436
Curr Opin Oncol. 1995 Nov;7(6):541-6
8547403
Breast Cancer Res Treat. 2004 May;85(1):1-12
15039593
Cancer Res. 1988 Mar 1;48(5):1195-200
3342399
Oncol Rep. 2004 Mar;11(3):681-5
14767522
Carcinogenesis. 2004 Jun;25(6):987-95
14742313
Genes Dev. 1999 Jan 15;13(2):152-7
9925639
Ann N Y Acad Sci. 2002 May;957:260-70
12074978
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2345-9
9122197
Cell. 1989 Jun 30;57(7):1083-93
2525423
Oncogene. 2003 Mar 6;22(9):1302-16
12618755
Science. 1997 Feb 21;275(5303):1129-32
9027314
Cancer Lett. 1999 Jan 29;135(2):151-7
10096423
Carcinogenesis. 1999 Sep;20(9):1737-45
10469619
Oncogene. 1994 Dec;9(12):3743-51
7970735
Cell. 1993 Aug 27;74(4):609-19
8358790
FASEB J. 1994 Jun;8(9):654-60
8005393
Int J Oncol. 2004 Mar;24(3):703-10
14767556
Ann Genet. 1994;37(3):121-34
7847793
Prostate. 1997 Sep 1;32(4):284-93
9288188
Cancer Metastasis Rev. 1992 Sep;11(2):121-39
1327566
Int J Cancer. 2004 Feb 20;108(5):733-40
14696100
Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6252-6
11972044
Science. 1998 Sep 25;281(5385):2027-31
9748162
Leukemia. 2001 Apr;15(4):515-22
11368354
Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2026-30
8134344
Biochim Biophys Acta. 2004 Mar 1;1644(2-3):133-47
14996498